S. Neijenhuis

Targeted radiosensitization of cells expressing truncated DNA polymerase {beta}.

Lenie J. van den Broek, A. Begg, C. Vens, 2010, Cancer research.

Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase beta.

A. Begg, E. Dikomey, C. Vens, 2009, DNA repair.

Radiosensitization by a dominant negative to DNA polymerase β is DNA polymerase β-independent and XRCC1-dependent

A. Begg, C. Vens, S. Neijenhuis, 2005 .

Radiosensitization by a dominant negative to DNA polymerase beta is DNA polymerase beta-independent and XRCC1-dependent.

A. Begg, C. Vens, S. Neijenhuis, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Identification of miRNA modulators to PARP inhibitor response.

A. Ashworth, C. Lord, I. Bajrami, 2013, DNA repair.

Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.

B. Westerman, R. Steenbergen, C. Oudejans, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Targeted radiosensitization by the Chk1 inhibitor SAR-020106.

J. Kyula, K. Harrington, M. Verheij, 2013, International journal of radiation oncology, biology, physics.

Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris

A. Witteveen, A. Glas, L. Delahaye, 2019, Translational oncology.